Exact Sciences Corp (NASDAQ: EXAS) reported Q4 EPS of ($0.18), $0.01 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $1.04 million versus the consensus estimate of $1.02 million.

For earnings history and earnings-related data on Exact Sciences Corp (EXAS) click here.

Earnings